The stock of GRI Bio Inc (GRI) has seen a 43.74% increase in the past week, with a 26.09% gain in the past month, and a -64.20% decrease in the past quarter. The volatility ratio for the week is 28.00%, and the volatility levels for the past 30 days are at 21.32% for GRI. The simple moving average for the last 20 days is 40.17% for GRI stock, with a simple moving average of -91.75% for the last 200 days.
Is It Worth Investing in GRI Bio Inc (NASDAQ: GRI) Right Now?
Company’s 36-month beta value is -1.70.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GRI is 2.92M, and currently, short sellers hold a 5.79% ratio of that floaft. The average trading volume of GRI on October 21, 2024 was 1.31M shares.
GRI) stock’s latest price update
GRI Bio Inc (NASDAQ: GRI) has seen a rise in its stock price by 18.61 in relation to its previous close of 0.49. However, the company has experienced a 43.74% gain in its stock price over the last five trading sessions. globenewswire.com reported 2024-10-16 that Data suggest that NKT cells are activated in airways in Idiopathic Pulmonary Fibrosis (IPF) patients and inhibition of iNKT cell activity can treat bleomycin-induced pulmonary fibrosis
GRI Trading at 24.05% from the 50-Day Moving Average
After a stumble in the market that brought GRI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.57% of loss for the given period.
Volatility was left at 21.32%, however, over the last 30 days, the volatility rate increased by 28.00%, as shares surge +31.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.75% upper at present.
During the last 5 trading sessions, GRI rose by +43.74%, which changed the moving average for the period of 200-days by -98.07% in comparison to the 20-day moving average, which settled at $0.4138. In addition, GRI Bio Inc saw -98.34% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GRI
Current profitability levels for the company are sitting at:
- -1.6 for the present operating margin
- 1.0 for the gross margin
The net margin for GRI Bio Inc stands at -1.53. The total capital return value is set at -1.79. Equity return is now at value -189.06, with -130.64 for asset returns.
Based on GRI Bio Inc (GRI), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -79.54.
Currently, EBITDA for the company is -11.33 million with net debt to EBITDA at 0.72. When we switch over and look at the enterprise to sales, we see a ratio of -0.84. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.11.
Conclusion
In a nutshell, GRI Bio Inc (GRI) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
